Pfizer Inc. (PFE) Stock Down on Earnings

November 1, 2011 - Shares of Pfizer Inc. (PFE) are down slightly in pre market this morning after the company just reported earnings. PFE stock is currently trading at $18.80.


Third-Quarter 2011 Revenues of $17.2 Billion

Third-Quarter 2011 Adjusted Diluted EPS(1) of $0.62; Reported Diluted EPS(2) of $0.48, which Reflects a $1.3 Billion After-Tax Gain on Sale of Capsugel(3)

Increases 2011 Adjusted Diluted EPS(1) and Reported Diluted EPS(2) Guidance Ranges; Reaffirms 2012 Financial Targets

Repurchases $2.1 Billion and $6.5 Billion of Common Stock During Third-Quarter and Year-to-Date through October 31, 2011, Respectively; Increases 2011 Share Repurchase Target to between $7 Billion and $9 Billion

http://daytradingstockblog.blogspot.com

Pfizer Inc. PFE Stock Analysis - 8/24/10

By Tim - http://stockstobuy.org

The following is technical analysis of Pfizer Inc. (PFE) stock for August 24, 2010

Pfizer Inc. (PFE) Support & Resistance Levels - 8/24/10

Resistance Levels: $16.60, $17.40

Support Levels: $15.14, $15

http://stockcharts.com - Chart

Pfizer Inc. (PFE) recently reported a blowout earnings report and is holding up very well despite the stock market decline. From a technical point of view, Pfizer Inc. is still in a long term downtrend but will break out of this downtrend when the stock closes above $17.40. Pfizer will have support at the 50 day moving average located at $15.14 so any pull backs to that level would be a strong buy.

For more Technical Analysis - Go Here

Today's Biggest Stock Market Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stocks for 2010

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/